Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01831739 · ClinicalTrials.gov registry record
Genomic Research in Sarcoidosis
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 368
- Enrollment target
NCT01831739 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 368 participants.
The verdict
NCT01831739 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 368 participants
- Enrollment target
Study Summary
This project is designed to address the following hypothesis: Distinct patterns in lung microbiome are characteristic of sarcoidosis phenotypes and reflected in changes in systemic inflammatory responses as measured by peripheral changes in gene transcription. The Specific Aims are: 1. To identify peripheral blood mononuclear cell (PBMC) gene expression patterns that characterize distinct sarcoidosis phenotypes. 2. To determine whether patterns in the lung microbiome are associated with sarcoidosis severity and disease phenotypes 3. To correlate mRNA and microRNA expression patterns in sarcoidosis affected organs with changes in microbiome, clinical parameters and PBMC gene expression patterns 4. To integrate clinical, transcriptomic, and microbiome data to identify novel molecular phenotypes in sarcoidosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 368 participants |
| Start Date | 2013-05 |
| Est. Completion | 2015-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01831739
The ClinicalTrials.gov registry entry for NCT01831739 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 368 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01831739 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01831739 about?
NCT01831739 is a clinical study titled "Genomic Research in Sarcoidosis". This project is designed to address the following hypothesis: Distinct patterns in lung microbiome are characteristic of sarcoidosis phenotypes and reflected in changes in systemic inflammatory responses as measured by peripheral changes in gene transcription. The Specific Aims are: 1. To identif...
What is the current status of trial NCT01831739?
This trial is currently completed. The enrollment target is 368 participants. The study started on 2013-05. Estimated completion is 2015-09.
Who is sponsoring clinical trial NCT01831739?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.